Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhoid Vaccines Cross-reactive Immunity (Ty21a-ASC)
NCT02121145Phase 4Unknown
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2013
- Primary completion
- Dec 2019
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of typhoid vaccine, live oral, salmonella typhi capsular polysaccharide vaccine in typhoid fever, salmonellosis, sponsored by Helsinki University Hospital. Status: unknown.
02
Drugs
typhoid vaccine, live oralsalmonella typhi capsular polysaccharide vaccine
03
Conditions
typhoid feversalmonellosis
Beyond the preview
Go deeper on NCT02121145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121145.